DOI QR코드

DOI QR Code

In vitro Screening of Oxime Reactivators on the Model of Paraoxon-inhibited Acetylcholinesterase-SAR Study

  • Holas, Ondrej (Department of Pharmaceutical Chemistry and Drug Control, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague) ;
  • Musilek, Kamil (Department of Toxicology, Faculty of Military Health Sciences) ;
  • Pohanka, Miroslav (Center of Advanced Studies, Faculty of Military Health Sciences) ;
  • Kuca, Kamil (Center of Advanced Studies, Faculty of Military Health Sciences) ;
  • Opletalova, Veronika (Department of Pharmaceutical Chemistry and Drug Control, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague) ;
  • Jung, Young-Sik (Bioorganic Science Division, Korea Research Institute of Chemical Technology)
  • Received : 2010.01.13
  • Accepted : 2010.04.12
  • Published : 2010.06.20

Abstract

Acetylcholinesterase reactivators are crucial antidotes for the treatment of organophosphate intoxication. Standard in vitro test was chosen using a rat brain homogenate as the source of AChE. Screening of reactivation potency was performed with two concentration of reactivator (1000 ${\mu}M$ and 10 ${\mu}M$). Results were compared to established reactivators pralidoxime, methoxime, HI-6, trimedoxime and obidoxime. More than 30 novel reactivators performed equal or better reactivation ability of POX-inhibited AChE compared to currently used reactivators. The structure-activity relationship for reactivators of paraoxon-inhibited AChE was developed.

Keywords

References

  1. Patocka, J.; Kuca, K.; Jun, D. Acta Medica 2004, 47, 215.
  2. Rosenberry, T. L. Adv. Enzymol. Relat. Areas Mol. Biol. 1975, 43,103.
  3. Quinn, D. M. Chem. Rev. 1987, 87, 955. https://doi.org/10.1021/cr00081a005
  4. Ekstrom, F.; Pang, Y. P.; Boman, M.; Artursson, E.; Akfur, C.; Borjegren,S. Biochem. Pharmacol. 2006, 72, 597. https://doi.org/10.1016/j.bcp.2006.05.027
  5. Harel, M.; Schalk, I.; Ehretsabatier, L.; Bouet, F.; Goeldner, M.;Hirth, C.; Axelsen, P. H.; Silman, I.; Sussman, J. L. PNAS 1993, 90,9031. https://doi.org/10.1073/pnas.90.19.9031
  6. Saxena, A.; Fedorko, J. M.; Vinayaka, C. R.; Medhekar, R.; Radic,Z.; Taylor, P.; Lockridge, O.; Doctor, B. P. Europ. J. Biochem.2003, 270, 4447. https://doi.org/10.1046/j.1432-1033.2003.03837.x
  7. Marrs, T. C. Pharmacol. Ther. 1993, 58, 51. https://doi.org/10.1016/0163-7258(93)90066-M
  8. Eddleston, M.; Buckley, N. A.; Eyer, P.; Dawson, A. H. Lancet2008, 371, 597. https://doi.org/10.1016/S0140-6736(07)61202-1
  9. Stone, D. L.; Sudakin, D. L. Clin. Toxicol. 2009, 47, 69. https://doi.org/10.1080/15563650802089523
  10. Bajgar, J. Adv. Clin. Chem. 2004, 38, 151. https://doi.org/10.1016/S0065-2423(04)38006-6
  11. Costa, L. G. Clin. Chim. Acta 2006, 366, 1. https://doi.org/10.1016/j.cca.2005.10.008
  12. Rosenstock, L.; Keifer, M.; Daniell, W. E.; Mcconnell, R.; Claypoole,K. Lancet 1991, 338, 223. https://doi.org/10.1016/0140-6736(91)90356-T
  13. Ekstrom, F.; Akfur, C.; Tunemalm, A. K.; Lundberg, S. Biochemistry2006, 45, 74. https://doi.org/10.1021/bi051286t
  14. Viragh, C.; Kovach, I. M.; Pannell, L. Biochemistry 1999, 38, 9557. https://doi.org/10.1021/bi991112+
  15. Bajgar, J.; Fusek, J.; Kuca, K.; Bartosova, L.; Jun, D. Mini. Rev. Med. Chem. 2007, 7, 461. https://doi.org/10.2174/138955707780619581
  16. Kassa, J. J. Toxicol. Clin. Toxicol. 2002, 40, 803. https://doi.org/10.1081/CLT-120015840
  17. Kuca, K.; Patocka, J.; Cabal, J.; Jun, D. Neurotox. Res. 2004, 6,565. https://doi.org/10.1007/BF03033452
  18. Kovarik, Z.; Calic, M.; Sinko, G.; Bosak, A.; Berend, S.; Vrdoljak,A. L.; Radic, B. Chem. Biol. Interact. 2008, 175, 173. https://doi.org/10.1016/j.cbi.2008.04.011
  19. Kuca, K.; Jun, D.; Musilek, K. Mini. Rev. Med. Chem. 2006, 6, 269. https://doi.org/10.2174/138955706776073510
  20. Musilek, K.; Kuca, K.; Jun, D.; Dolezal, M. Curr. Org. Chem.2007, 11, 229. https://doi.org/10.2174/138527207779316417
  21. Pohanka, M.; Karasova, J. Z.; Musilek, K.; Kuca, K.; Kassa, J. J. Appl. Toxicol. 2009, 29, 483. https://doi.org/10.1002/jat.1432
  22. Eddleston, M.; Phillips, M. R. Brit. Med. J. 2004, 328, 42. https://doi.org/10.1136/bmj.328.7430.42
  23. Jun, D.; Musilova, L.; Kuca, K.; Kassa, J.; Bajgar, J. Chem. Biol. Interact.2008, 175, 421. https://doi.org/10.1016/j.cbi.2008.05.004
  24. Musilek, K.; Holas, O.; Kuca, K.; Jun, D.; Dohnal, V.; Opletalova,V.; Dolezal, M. Bioorg. Med. Chem. Lett. 2007, 17, 3172. https://doi.org/10.1016/j.bmcl.2007.03.025
  25. Park, N. J.; Jung, Y. S.; Musilek, K.; Jun, D.; Kuca, K. Bull. Korean Chem. Soc. 2006, 27, 1401. https://doi.org/10.5012/bkcs.2006.27.9.1401
  26. Kuca, K.; Jun, D.; Bajgar, J. Drug Chem. Toxicol. 2007, 30, 31. https://doi.org/10.1080/01480540601017637
  27. Tattersall, J. E. Br. J. Pharmacol. 1993, 108, 1006. https://doi.org/10.1111/j.1476-5381.1993.tb13498.x
  28. Eddleston, M.; Eyer, P.; Worek, F.; Mohamed, F.; Senarathna, L.;von Meyer, L.; Juszczak, E.; Hittarage, A.; Azhar, S.; Dissanayake,W.; Sheriff, M. H. R.; Szinicz, L.; Dawson, A. H.; Buckley, N. A.Lancet 2005, 366, 1452. https://doi.org/10.1016/S0140-6736(05)67598-8
  29. Kuca, K.; Jun, D.; Bajgar, J. Curr. Pharm. Design 2007, 13, 3445.
  30. Kuca, K.; Racakova, V.; Jun, D. Chem. Pap. 2007, 61, 256. https://doi.org/10.2478/s11696-007-0030-7
  31. Musilek, K.; Holas, O.; Kuca, K.; Jun, D.; Dohnal, V.; Opletalova,V.; Dolezal, M. J. Enzym. Inhib. Med. Chem. 2008, 23, 70. https://doi.org/10.1080/14756360701383981
  32. Cabal, J.; Kuca, K.; Kassa, J. Bas. Clin. Pharmacol. Toxicol. 2004,95, 81. https://doi.org/10.1111/j.1742-7843.2004.950207.x
  33. Musilek, K.; Holas, O.; Hambalek, J.; Kuca, K.; Jun, D.; Dohnal,V.; Dolezal, M. Lett. Org. Chem. 2006, 3, 831. https://doi.org/10.2174/157017806779117012
  34. Sakurada, K.; Matsubara, K.; Shimizu, K.; Shiono, H.; Seto, Y.;Tsuge, K.; Yoshino, M.; Sakai, I.; Mukoyama, H.; Takatori, T.Neurochem. Res. 2003, 28, 1401. https://doi.org/10.1023/A:1024960819430
  35. Okuno, S.; Sakurada, K.; Ohta, H.; Ikegaya, H.; Kazui, Y.; Akutsu,T.; Takatori, T.; Iwadate, K. Toxicol. Appl. Pharmacol. 2008,227, 8. https://doi.org/10.1016/j.taap.2007.09.021
  36. Musilek, K.; Holas, O.; Kuca, K.; Jun, D.; Dohnal, V.; Dolezal, M.Bioorg. Med. Chem. Lett. 2006, 16, 5673. https://doi.org/10.1016/j.bmcl.2006.08.011
  37. Musilek, K.; Holas, O.; Kuca, K.; Jun, D.; Dohnal, V.; Dolezal, M.J. Enzym. Inhib. Med. Chem. 2007, 22, 425. https://doi.org/10.1080/14756360601164960
  38. Musilek, K.; Holas, O.; Jun, D.; Dohnal, V.; Gunn-Moore, F.; Opletalova,V.; Dolezal, M.; Kuca, K. Bioorg. Med. Chem. 2007, 15,6733. https://doi.org/10.1016/j.bmc.2007.08.002